Variant report
Variant | nsv1029346 |
---|---|
Chromosome Location | chr9:9385317-9395912 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs150558761 | chr9:9385328-9385329 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs183242610 | chr9:9385350-9385351 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs10816108 | chr9:9385356-9385357 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs567419929 | chr9:9385360-9385361 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs186489641 | chr9:9385366-9385367 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs546670674 | chr9:9385381-9385382 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs1023217 | chr9:9385401-9385402 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs372554593 | chr9:9385418-9385419 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs527452881 | chr9:9385420-9385421 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs191250187 | chr9:9385423-9385424 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs142140785 | chr9:9385437-9385438 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs537718935 | chr9:9385486-9385487 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs555810884 | chr9:9385488-9385489 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs184541086 | chr9:9385489-9385490 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs564752295 | chr9:9385490-9385491 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs10816109 | chr9:9385507-9385508 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs151197548 | chr9:9385522-9385523 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs561014557 | chr9:9385536-9385537 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs10816110 | chr9:9385560-9385561 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs563732723 | chr9:9385583-9385584 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs140339403 | chr9:9385604-9385605 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs150218121 | chr9:9385610-9385611 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs561027318 | chr9:9385626-9385627 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs10977709 | chr9:9385640-9385641 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs10977710 | chr9:9385651-9385652 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs188179840 | chr9:9385656-9385657 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs532279664 | chr9:9385681-9385682 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs192773886 | chr9:9385694-9385695 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs4400438 | chr9:9385717-9385718 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs141528902 | chr9:9385722-9385723 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs535875795 | chr9:9385729-9385730 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs185156406 | chr9:9385754-9385755 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs147040584 | chr9:9385755-9385756 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs567657654 | chr9:9385757-9385758 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs138523569 | chr9:9385774-9385775 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs553176371 | chr9:9385790-9385791 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs577698522 | chr9:9385803-9385804 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs545450833 | chr9:9385881-9385882 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs149641646 | chr9:9385898-9385899 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs575546560 | chr9:9385950-9385951 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs542663189 | chr9:9386045-9386046 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs371748506 | chr9:9386070-9386071 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs189167294 | chr9:9386113-9386114 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs181778902 | chr9:9386123-9386124 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs143321429 | chr9:9386133-9386134 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs565039097 | chr9:9386135-9386136 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs10977711 | chr9:9386162-9386163 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs568871686 | chr9:9386163-9386164 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs184957520 | chr9:9386180-9386181 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs189630247 | chr9:9386188-9386189 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
abnormal development | 18461090 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
XY gonadal dysgenesis | 20685758 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma | 19074898 | CNVD |
Malignant melanoma | 19074898 | CNVD |
Prostate cancer | 16573809 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Cancer | 20164920 | CNVD |
Lung cancer | 20668451 | CNVD |
Schizophrenia | 20838587 | CNVD |
Glioblastoma | 18772890 | CNVD |
Glioblastoma multiforme | 21390271 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 20858261 | CNVD |
Epilepsy | 20858261 | CNVD |
Mental retardation | 20858261 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 21764851 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioma | 17123091 | CNVD |
Lung cancer | 16773561 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Gastric cancer | 16891809 | CNVD |
Mental retardation | 17847001 | CNVD |
Cutaneous squamous cell carcinomas | 17420988 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:9384800-9385600 | Enhancers | Pancreatic Islets | Pancreatic Islet |
2 | chr9:9385200-9385600 | Enhancers | Stomach Mucosa | stomach |
3 | chr9:9385400-9385800 | Enhancers | Aorta | Aorta |
4 | chr9:9385600-9390800 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
5 | chr9:9386800-9387200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
6 | chr9:9387600-9387800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
7 | chr9:9387800-9389600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
8 | chr9:9389600-9390000 | Flanking Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
9 | chr9:9390000-9390800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
10 | chr9:9390800-9391000 | Flanking Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
11 | chr9:9390800-9391000 | Enhancers | Pancreatic Islets | Pancreatic Islet |
12 | chr9:9391000-9391400 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
13 | chr9:9391000-9391600 | Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
14 | chr9:9391400-9391800 | Enhancers | Pancreatic Islets | Pancreatic Islet |
15 | chr9:9391600-9392200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
16 | chr9:9392600-9393200 | Active TSS | Rectal Mucosa Donor 29 | rectum |